When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 26 Hits
  • Search Condition : Filter (MeSH = Cholangiocarcinoma / metabolism)
Species Resource Title
Human and Animal Cells G-415(RCB2640) Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) , TFK-1(RCB2537) Extracellular RNA transfer from non-malignant human cholangiocytes can promote cholangiocarcinoma growth.
Human and Animal Cells SSP-25(RCB1293), RBE(RCB1292) Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
Human and Animal Cells HuCCT1(RCB1960) , TFK-1(RCB2537) , HuH-28(RCB1943) E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.
Human and Animal Cells SSP-25(RCB1293) Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
Human and Animal Cells SSP-25(RCB1293) Autophagy Plays a Role in the CUL4A-Related Poor Prognosis of Intrahepatic Cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
Human and Animal Cells Hep G2(RCB1648) , HuH-7(RCB1366) The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.
Human and Animal Cells SSP-25(RCB1293) , TFK-1(RCB2537) Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma.
Human and Animal Cells HuCCT1(RCB1960) IDH1 mutation correlates with a beneficial prognosis and suppresses tumor growth in IHCC.
Human and Animal Cells HuCCT1(RCB1960) Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) , HuH-28(RCB1943) Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma.
Human and Animal Cells TGBC1TKB(RCB1129) p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion.
Human and Animal Cells SSP-25(RCB1293) , HuH-28(RCB1943) CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis.
Human and Animal Cells HuCCT1(RCB1960) , RBE(RCB1292) Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma.
Human and Animal Cells HuH-28(RCB1943) Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity.
Human and Animal Cells TFK-1(RCB2537) Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.
Human and Animal Cells HuCCT1(RCB1960) , RBE(RCB1292) GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.
Human and Animal Cells Hep G2(RCB1886) Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein.